Post‐transplantation lymphoproliferative disorders localizing to the gastrointestinal tract after liver transplantation: Report of five pediatric cases
- 2 May 2006
- journal article
- case report
- Published by Wiley in Pediatric Transplantation
- Vol. 10 (3) , 390-394
Abstract
Post‐transplantation lymphoproliferative disorder (PTLD) is a life‐threatening complication of organ transplantation. PTLD can occur in every kind of organ transplantation. From July 1992 to July 2004, five patients were diagnosed at our transplantation center with PTLD after pediatric liver transplantation. During this period, there were 52 pediatric patients (in situ was demonstrated in each case. EBV viral load was noted to be an important risk factor. Treatment included dose reduction of immunosuppressants and anti‐CD20 antibody infusion. Chemotherapy, including cyclophosphamide, doxorubicin, vincristine, and prednisolone, was given to three patients. Four patients have survived more than 10 months until now after treatment. The one who was unresponsive to chemotherapy and anti‐CD20 antibody had diffuse metastasis and died of systemic candidiasis. In our series, each PTLD involved the GI tract. The mechanism of this phenomenon is unclear, but these five cases indicate the high incidence of PTLD in pediatric solid organ transplantation.Keywords
This publication has 18 references indexed in Scilit:
- Posttransplantation lymphoproliferative disorder in pediatric liver transplantationTransplantation Proceedings, 2004
- The value of prospective monitoring of Epstein–Barr virus DNA in blood samples of pediatric liver transplant recipientsTransplant Infectious Disease, 2004
- Successful treatment of posttransplant lymphoproliferative disease with prolonged rituximab treatment in intestinal transplant recipientsTransplantation, 2002
- Lymphoproliferation in Children After Liver TransplantationJournal of Pediatric Gastroenterology and Nutrition, 2002
- Frequent monitoring of Epstein-Barr virus DNA load in unfractionated whole blood is essential for early detection of posttransplant lymphoproliferative disease in high-risk patientsBlood, 2001
- Identification of Prognostic Factors in 61 Patients With Posttransplantation Lymphoproliferative DisordersJournal of Clinical Oncology, 2001
- SERIAL MEASUREMENT OF EPSTEIN-BARR VIRAL LOAD IN PERIPHERAL BLOOD IN PEDIATRIC LIVER TRANSPLANT RECIPIENTS DURING TREATMENT FOR POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE1Transplantation, 1998
- Epstein-Barr virus-related localized hepatic lymphoproliferative disorders after liver transplantationCancer, 1995
- Posttransplantation lymphoproliferative disorders treated with cyclophosphamide-doxorubicin-vincristine-prednisone chemotherapyCancer, 1993
- A RECENT DECREASE IN THE TIME TO DEVELOPMENT OF MONOMORPHOUS AND POLYMORPHOUS POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDERTransplantation, 1992